| Code | CSB-AP001581RA |
| Abbreviation | Recombinant Rat Ccl22 protein, partial (Active) |
| MSDS | |
| Size | $142 |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
CCL22 (MDC) is a key CCR4 ligand that drives Th2 and regulatory T cell recruitment, making it central to studies of immune tolerance, allergic inflammation, and tumor immune evasion. This tag-free recombinant rat CCL22 (residues 14–81) encompasses the mature protein sequence and demonstrates robust chemotactic activity on human T-lymphocytes at 10–100 ng/ml, supporting direct use in chemotaxis and migration assays, CCR4-dependent signaling pathway analyses, and in vivo rat models of inflammation or tumor biology. Endotoxin levels below 1.0 EU/μg minimize LPS-driven artifacts in sensitive immune cell functional assays, which aligns with standards expected in T cell activation studies, antibody development workflows, and use as a reference standard in cytokine detection platforms such as ELISA. Produced in *E. coli* with purity exceeding 96% by SDS-PAGE, this preparation provides a suitable basis for quantitative bioassays where consistent lot-to-lot potency is essential.
There are currently no reviews for this product.